might interest some....Bristol Myers beats estimates with new drug sales surge
Bristol Myers Squibb ($BMY) outperformed in Q4 with adjusted earnings per share of $1.70 (compared to the expected $1.53) and revenue of $11.48B (surpassing the expected $11.19B). The sales boost was driven by higher sales of new drugs, including Reblozyl and Opdualag, contributing $1.07B, up 66% from the previous year.
fwiw...Opdualag had sales of $190M for 4th qtr of 2023, contrast this with sales of $45M for 3rd qtr 2022..
- Forums
- ASX - By Stock
- Media
might interest some....Bristol Myers beats estimates with new...
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M |
Open | High | Low | Value | Volume |
33.5¢ | 34.8¢ | 33.5¢ | $932.8K | 2.725M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29411 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 938315 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29411 | 0.340 |
6 | 273525 | 0.335 |
16 | 241153 | 0.330 |
9 | 183545 | 0.325 |
11 | 176561 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 938315 | 11 |
0.355 | 56273 | 4 |
0.360 | 60273 | 3 |
0.365 | 53245 | 4 |
0.370 | 170757 | 5 |
Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |